ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

Shared Specimen Resource Needed, GYN Review Finds.

February 1, 2002

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003